João Faro-Viana

Population homogeneity for the antibody response to COVID-19 BNT162b2/Comirnaty vaccine is only reached after the second dose across all adult age ranges

J. Demengeot, M. Bergman, P. Alves, 2022, Nature communications.

Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up

J. Demengeot, M. Bergman, O. Akpogheneta, 2021, Frontiers in Medicine.